400
Participants
Start Date
May 16, 2023
Primary Completion Date
April 30, 2027
Study Completion Date
April 30, 2029
Vanquish System
Water vapor ablation delivered transurethrally in patients with intermediate risk, localized prostate cancer.
NYU Langone Health, New York
Northwell Health- Lenox Hill Hospital, New York
University of Rochester, Rochester
MidLantic Urology, Bala-Cynwyd
Chesapeake Urology, Baltimore
Johns Hopkins, Baltimore
Urology of Virginia, PLLC, Virginia Beach
Duke Cancer Institute, Durham
Carolina Urologic Research Center, Myrtle Beach
Kasraeian Urology, Jacksonville
The Urology Group, Cincinnati
Corewell Health / William Beaumont University Hospital, Royal Oak
Michigan Institute of Urology, Troy
Medical College of Wisconsin, Milwaukee
Minnesota Urology, Woodbury
University of Minnesota, Minneapolis
Mayo Clinic- Rochester, Rochester
University of Chicago, Chicago
Wichita Urology, Wichita
WK Advanced Urology Specialists, Shreveport
Houston Methodist Hospital and Research Institute, Houston
The Urology Place, San Antonio
Urology Austin, Austin
Mayo Clinic- Phoenix, Phoenix
University of Southern California, Los Angeles
Memorial Care, Laguna Hills
Lead Sponsor
Francis Medical Inc.
INDUSTRY